NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway
about
Type I interferon protects against pneumococcal invasive disease by inhibiting bacterial transmigration across the lungRegulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophagesInterleukin-10-mediated Inhibition of free radical generation in macrophagesIkappaBalpha and IkappaBalpha /NF-kappa B complexes are retained in the cytoplasm through interaction with a novel partner, RasGAP SH3-binding protein 2Respiratory syncytial virus-inducible BCL-3 expression antagonizes the STAT/IRF and NF-kappaB signaling pathways by inducing histone deacetylase 1 recruitment to the interleukin-8 promoterCSN controls NF-kappaB by deubiquitinylation of IkappaBalphaTRAF3 controls activation of the canonical and alternative NFkappaB by the lymphotoxin beta receptorActivation of RelA homodimers by tumour necrosis factor alpha: a possible transcriptional activator in human vascular endothelial cellsThe ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-kappaB signallingThe kinase IKKα inhibits activation of the transcription factor NF-κB by phosphorylating the regulatory molecule TAX1BP1BCL3 encodes a nuclear protein which can alter the subcellular location of NF-kappa B proteinsCoupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activationPositive regulation of IkappaB kinase signaling by protein serine/threonine phosphatase 2AA novel NF-kappa B complex containing p65 homodimers: implications for transcriptional control at the level of subunit dimerizationProtein methyltransferase 2 inhibits NF-kappaB function and promotes apoptosisEssential role for TAX1BP1 in the termination of TNF-alpha-, IL-1- and LPS-mediated NF-kappaB and JNK signaling3-Phosphoinositide-dependent protein kinase-1-mediated IkappaB kinase beta (IkkB) phosphorylation activates NF-kappaB signalingDNA-dependent protein kinase phosphorylation of IkappaB alpha and IkappaB beta regulates NF-kappaB DNA binding propertiesA TNF-induced gene expression program under oscillatory NF-kappaB controlI kappa B alpha-mediated inhibition of v-Rel DNA binding requires direct interaction with the RXXRXRXXC Rel/kappa B DNA-binding motifStimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neuronsA proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa BThe glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domainFailure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient miceNF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like moleculePathogen recognition and inflammatory signaling in innate immune defensesI kappaB alpha physically interacts with a cytoskeleton-associated protein through its signal response domainA new member of the I kappaB protein family, I kappaB epsilon, inhibits RelA (p65)-mediated NF-kappaB transcriptionPhysical and functional interaction between the human T-cell lymphotropic virus type 1 Tax1 protein and the CCAAT binding protein NF-YRole of unphosphorylated, newly synthesized I kappa B beta in persistent activation of NF-kappa BRegulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factorsRelA Ser276 phosphorylation is required for activation of a subset of NF-kappaB-dependent genes by recruiting cyclin-dependent kinase 9/cyclin T1 complexesCytoskeletal control of gene expression: depolymerization of microtubules activates NF-kappa BTransdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplicationActivation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1At the crossroads of SUMO and NF-kappaBDevelopment of a method for screening short-lived proteins using green fluorescent proteinRegulation of IkappaBalpha expression involves both NF-kappaB and the MAP kinase signaling pathways.NF-κB, the first quarter-century: remarkable progress and outstanding questionsNF-κB in inflammation and renal diseases
P2860
Q21131368-64A9D01E-2C42-4412-AA4F-D5CE8E1D4EE4Q21296830-CA02F044-9876-433B-9C0F-B33882B8559AQ23923216-97E0AFB0-BE50-482E-9D82-B1502A106472Q24290171-7F36D18E-C02C-402A-881B-D711209AF649Q24296927-76547496-88E2-4B76-9B17-315AD00370D6Q24298155-CCDCDF41-13C2-4054-8A6D-C178A4817E38Q24300996-02A16013-11F8-45FB-95AC-82115C1E1232Q24301448-4AAAA467-2E5B-4CDF-9A72-06212D4F756AQ24314649-C737B81C-D6C5-412B-B384-5731720E524EQ24315115-B4175EAF-DE50-4FD2-BC48-D8647F93ED9AQ24315909-1D870BD9-19DD-4058-8DAB-7807E84DF6D2Q24316905-281300CC-5FA2-4802-91F0-1D2072B24801Q24318289-E94B4067-C323-4F38-AD9F-D1502869CAA5Q24320246-D8CFE262-D418-409B-B430-DDB837FCDC5CQ24322824-AF94529C-7DAA-4C9C-A548-5B6E16CA8200Q24337661-1719864A-6D2B-4852-94D4-146989E2E7C9Q24337691-8DBEDA87-B0BE-429F-A47A-82D03BA08223Q24522560-14617CFA-6ADC-40CD-B660-95BF1987D16AQ24534458-EE716CA5-2BC9-4606-A3BC-E2ACAA52AA1BQ24561403-093AC00C-3C9C-4BC0-9152-B46E5860450BQ24563145-405B7C86-F09F-4E71-8D0E-CC146FFA68D3Q24568234-A2316B47-B6C3-4094-BCF8-ABAF0516526EQ24600925-469AB486-3E1B-40C0-A8EB-5C2F9F118DBCQ24616207-9CD950E1-A9AD-45EB-BAD9-C82941EE1CB7Q24629772-C45E2367-B750-4108-B6D2-7062CE4A283DQ24643034-B6495726-799E-46BE-9DB8-624687717898Q24643936-AB12DB41-E68D-4198-AC93-C60B3175FAA0Q24644412-97EC0188-5BFA-40E4-B566-DCB2D20B5230Q24647157-51272381-88B7-42CE-BE19-1DDD791F0892Q24648375-CDB4CF59-C7AC-45D6-8999-8F7B7287D32AQ24651506-592AF658-4CF5-49A1-A841-F6680ADCD4C3Q24658047-B6D6CDAB-E87C-4D87-BC9E-BF58B2806E78Q24672676-11E4DED3-B3DF-4A24-AF3B-6D17228D0E7EQ24681560-FE7423ED-6185-43BC-A508-2C4711995C95Q24682560-BEF458EB-E8B8-43CD-9877-6D2EA1FBF328Q24798022-4B256E34-D96D-4AD9-B12E-78E801E998FEQ24809496-4C1F70C1-293F-4A07-8596-AEA0D4ADA55AQ24815441-9C617E58-DF5A-44CB-8797-233C1E2166EAQ26822516-F73C4222-1B68-4E37-A2B7-0800D3AEA0C3Q27021276-BD32EF62-629D-427E-AA58-4FB4D5D0A29A
P2860
NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway
description
1993 nî lūn-bûn
@nan
1993 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի մարտին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
NF-kappa B controls expression ...... ducible autoregulatory pathway
@ast
NF-kappa B controls expression ...... ducible autoregulatory pathway
@en
NF-kappa B controls expression ...... ducible autoregulatory pathway
@en-gb
NF-kappa B controls expression ...... ducible autoregulatory pathway
@nl
type
label
NF-kappa B controls expression ...... ducible autoregulatory pathway
@ast
NF-kappa B controls expression ...... ducible autoregulatory pathway
@en
NF-kappa B controls expression ...... ducible autoregulatory pathway
@en-gb
NF-kappa B controls expression ...... ducible autoregulatory pathway
@nl
prefLabel
NF-kappa B controls expression ...... ducible autoregulatory pathway
@ast
NF-kappa B controls expression ...... ducible autoregulatory pathway
@en
NF-kappa B controls expression ...... ducible autoregulatory pathway
@en-gb
NF-kappa B controls expression ...... ducible autoregulatory pathway
@nl
P2093
P921
P3181
P356
P1433
P1476
NF-kappa B controls expression ...... ducible autoregulatory pathway
@en
P2093
P304
P3181
P356
10.1126/SCIENCE.8096091
P407
P577
1993-03-26T00:00:00Z